人类转化生长因子β型I受体与激酶抑制剂SB505124复合体中的复合体
Jhon A Rodriguez Buitrago1, Maréne Landström2, Magnus Wolf-Watz2
1Department of Chemistry, Umeå University, Linnaeus vag 10, 901 87 Umeå, Sweden.
Acta crystallographica. Section F, Structural biology communications
|October 23, 2024
概括
这项研究揭示了转化生长因子β型I受体 (TβR1) 与SB505124.4结合的晶体结构. 这为抑制关键癌症信号通路提供了分子洞察力,突出显示了SB5051244.
科学领域:
- 生物化学 生化学
- 结构生物学 结构生物学
- 分子生物学分子生物学
背景情况:
- 转化生长因子β (TGF-β) 信号在细胞过程中至关重要.
- 调节TGF-β信号的失调与各种癌症有关.
- 准TGF-β I型受体 (TβR1) 是一种治疗策略.
研究的目的:
- 为了确定TβR1细胞内域的晶体结构.
- 阐明与抑制剂SB505124.4的分子相互作用.
- 了解TβR1抑制的机制.
主要方法:
- 在X射线晶体学.
- 蛋白质的表达和净化过程
- 生物化学测定 生物化学测定
主要成果:
- 解决了与SB505124复合的TβR1的晶体结构.
- 确定了TβR1和SB505124之间的详细分子相互作用.
- 该结构为理解TβR1抑制提供了基础.
结论:
- 呈现的结构为SB505124.4对TβR1抑制提供了分子层面的见解.
- 这种理解可以指导开发新型癌症疗法.
- 在癌症中,SB505124显示出作为向TGF-β信号的治疗剂的潜力.
更多相关视频
相关概念视频
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Receptor Tyrosine Kinases
12.4K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.4K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Enzyme-linked Receptors
77.4K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.4K


